Leaderboards/Hemophilia Treatment and Research

Hemophilia Treatment and Research

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Xiaoqiang Shang
Wuhan Red Cross Hospital
2
Dino Mehic
Medical University of Vienna
3
Erna C. van Balen
National Institute for Public Health and the Environment
4
Assaf A. Barg
Tel Aviv University
5
Nancy S. Bolous
St. Jude Children's Research Hospital
6
Azusa Nagao
Kansai Medical University
7
Shermarke Hassan
The Netherlands Cancer Institute
8
Anne‐Fleur Zwagemaker
Emma Kinderziekenhuis
9
Anouk A. M. T. Donners
Utrecht University
10
Michela Milani
The San Raffaele Telethon Institute for Gene Therapy

Rising Stars Papers

1
GP64-pseudotyped lentiviral vectors target liver endothelial cells and correct hemophilia A mice
EMBO Molecular Medicine|2024
14 cit.
2
Artificial intelligence–assisted ultrasound imaging in hemophilia: research, development, and evaluation of hemarthrosis and synovitis detection
Research and Practice in Thrombosis and Haemostasis|2024
12 cit.
3
In vivo haemopoietic stem cell gene therapy enabled by postnatal trafficking
Nature|2025
12 cit.
4
Plasmin generation analysis in patients with bleeding disorder of unknown cause
Blood Advances|2024
10 cit.
5
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause
Journal of Thrombosis and Haemostasis|2025
9 cit.
6
Activated protein C and free protein S in patients with mild to moderate bleeding disorders
Thrombosis Research|2024
6 cit.
7
Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study
Research and Practice in Thrombosis and Haemostasis|2024
5 cit.
8
Antithrombotic Therapy in People with Hemophilia—A Narrative Review
Thrombosis and Haemostasis|2025
5 cit.
9
Identification of hepatocyte-primed cholangiocytes in the homeostatic liver by in vivo lentiviral gene transfer to mice and non-human primates
Cell Reports|2025
4 cit.
10
Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering
Journal of Hepatology|2025
4 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Samantha C. Gouw
Amsterdam Neuroscience
2
Craig C Benson
Sanofi (United States)
3
Rubén Cuesta‐Barriuso
Universidad de Oviedo
4
Gallia G. Levy
University of Michigan–Ann Arbor
5
Saskia E.M. Schols
Radboud University Nijmegen
6
Mark W. Skinner
Center For Policy Research
7
Jamie O’Hara
University of Chester
8
Karin Knobe
Sanofi (France)
9
Tyler W. Buckner
University of Colorado Denver
10
Daniel‐Anibal Garcia Diego
Federación Española de Enfermedades Raras

Emerging Leaders Papers

1
Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A
New England Journal of Medicine|2023
183 cit.
2
Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: A prospective multicenter observational study
Journal of Thrombosis and Haemostasis|2022
40 cit.
3
The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making
Patient Preference and Adherence|2022
36 cit.
4
Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study
Haemophilia|2022
36 cit.
5
The bleeding phenotype in people with nonsevere hemophilia
Blood Advances|2022
32 cit.
6
The Impact of Pharmacokinetic-Guided Prophylaxis on Clinical Outcomes and Healthcare Resource Utilization in Hemophilia A Patients: Real-World Evidence from the CHESS II Study
Journal of Blood Medicine|2022
24 cit.
7
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science
Expert Review of Hematology|2023
23 cit.
8
Treatment of patients with rare bleeding disorders in the Netherlands: Real‐life data from the RBiN study
Journal of Thrombosis and Haemostasis|2022
22 cit.
9
Differential humanistic and economic burden of mild, moderate and severe haemophilia in european adults: a regression analysis of the CHESS II study
Orphanet Journal of Rare Diseases|2022
21 cit.
10
Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysis
Research and Practice in Thrombosis and Haemostasis|2023
21 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Kenneth G. Mann
Haematologic Technologies (United States)
2
Victor S. Blanchette
University of Toronto
3
Pieter H. Reitsma
Leiden University Medical Center
4
Pier Mannuccio Mannucci
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
5
Glenn F. Pierce
Hemophilia Federation of America
6
Frits R. Rosendaal
Leiden University Medical Center
7
Midori Shima
Nara Medical University
8
John H. Griffin
Scripps Research Institute
9
Maureane Hoffman
Duke University
10
Johannes Oldenburg
University Hospital Bonn

Current Senior Leaders Papers

1
Mutation in blood coagulation factor V associated with resistance to activated protein C
Nature|1994
3.8k cit.
2
Hematological Problems in Pediatric Intensive Care
Pediatric and adolescent medicine|2013
3.5k cit.
3
A Cell-based Model of Hemostasis
Thrombosis and Haemostasis|2001
1.5k cit.
4
Deficiency of protein C in congenital thrombotic disease.
Journal of Clinical Investigation|1981
1.3k cit.
5
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
Nature|2004
1.1k cit.
6
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
New England Journal of Medicine|2017
1.1k cit.
7
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
New England Journal of Medicine|1996
1.1k cit.
8
Definitions in Hemophilia
Thrombosis and Haemostasis|2001
771 cit.
9
Definitions in hemophilia: communication from the SSC of the ISTH
Journal of Thrombosis and Haemostasis|2014
751 cit.
10
Geographic Distribution of the 20210 G to A Prothrombin Variant
Thrombosis and Haemostasis|1998
702 cit.

Reagents for Hemophilia Treatment and Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

ACO2 Antibody

#6922$317
View Evidence →
Cell Signaling Technology

Total Rb Matched Antibody Pair

#18865$1,726
View Evidence →
Cell Signaling TechnologyEvidence 66

Progesterone Receptor A/B (D8Q2J) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#35591$465
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 68

ANP32A (D7Z5U) Rabbit Monoclonal Antibody

#15491$161,351
View Evidence →
Cell Signaling Technology

Tissue Factor/CD142 (E2L3B) Rabbit Monoclonal Antibody

#44861$161,351
View Evidence →
Cell Signaling Technology

CasMINI (8H6-A8) Mouse Monoclonal Antibody (BSA and Azide Free)

#44840$865
View Evidence →